Screen readers: Two navigational links to follow.Skip to site navigation.Skip to page content.
The University of Iowa News Services
The University of Iowa News Services Home News Releases UI in the News Subscribe to UI News Contact Us

University of Iowa News Release

 

Aug. 23, 2007

Weiner to lead national cancer center review group

The National Cancer Institute (NCI) has appointed a University of Iowa cancer researcher to serve as chair of the committee that determines which cancer centers in the United States become NCI-designated cancer centers.

Paulette Gray, Ph.D., director of the NCI's Division of Extramural Affairs, announced that George Weiner, M.D., director of the Holden Comprehensive Cancer Center at the UI, has accepted the position of chair of the NCI Initial Review Group - Subcommittee A - Cancer Centers. Weiner will serve in the post, beginning immediately, through June 30, 2008.

"I am deeply honored to accept this position," Weiner said. "The NCI-designated cancer centers provide the foundation for the laboratory, clinical and community cancer research taking place in the United States. I look forward to doing my part to strengthen even further this vital component of our national cancer effort."

Established in 1980, Holden Comprehensive Cancer Center is the only NCI-designated comprehensive cancer center in Iowa, and one of just 39 nationwide. NCI designation follows an exhaustive NCI review, including evaluation of a major written proposal and an on-site visit by cancer scientists and physicians from the committee now chaired by Weiner.

Weiner began his service as director of Holden Comprehensive Cancer Center in 1998. He is also the C.E. Block Chair of Cancer Research at the UI. In addition, he serves as chair of the Iowa Comprehensive Cancer Control Consortium.

Weiner's clinical interests include medical oncology and hematology with a special interest in the treatment of lymphoma and leukemia. His clinical and laboratory research focuses on the immunotherapy of lymphoma and leukemia, including the development and evaluation of genetically modified monoclonal antibody constructs and development of novel immune adjuvants for cancer immunization. He graduated from medical school at Ohio State University, followed by residency training at the Medical College of Ohio and a fellowship at the University of Michigan.

Holden Comprehensive Cancer Center is Iowa's only National Cancer Institute (NCI)-designated comprehensive cancer center. NCI-designated comprehensive cancer centers are recognized as the leaders in developing new approaches to cancer prevention and cancer care, conducting leading-edge research and educating the public about cancer.

STORY SOURCE: Joint Office for Marketing and Communications, University of Iowa Health Care, 200 Hawkins Drive, Room E110 GH, Iowa City, Iowa 52242-1009

MEDIA CONTACT: Tom Moore, 319-356-3945, thomas-moore@uiowa.edu.